who discovered glp-1 The Discovery of Glucagon-Like Peptide 1 (GLP-1) JCI - Discovery, characterization, and

In clinical studies, subjects often began to exhibit noticeable biological effects 45 minutes to 2 hours after subcutaneous administration

Its creamy gel formula is boosted by super antioxidant acetyl zingerone & phyto exosomes for advanced age defence and fast brightening results

Adverse effects of incretin mimetics Potential adverse effects of incretin mimetics include: Hypoglycemia when taken with insulin GI distress Pancreatitis Renal insufficiency Possible risk of thyroid cancer Other non-insulin, injectable diabetes medications GIP/GLP-1 receptor co-agonists GIP/GLP-1 receptor co-agonists are used to treat type 2 diabetes only

Step-by-Step Reconstitution: Reconstitute the vial with 10ml of Sterile Water for Injections IP (included in the pack)